Lucid Diagnostics revenue was $4.35M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $1.2M, up 2.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, LUCD annual revenue was $4.3M, with 79% growth year-over-year.
LUCD past revenue growth
How has LUCD's revenue growth performed historically?
Lucid Diagnostics (NASDAQ: LUCD) reported Q4 2024 revenue of $1.20 million up 15.1% year over year. In the same quarter last year, Lucid Diagnostics's revenue was $1.04 million.
What was Lucid Diagnostics's revenue in 2024?
Lucid Diagnostics's annual revenue for the twelve months ending Dec 31, 2024 was $4.35 million, a 79% increase year over year.
How much does Lucid Diagnostics make in a day?
Based on Lucid Diagnostics annual revenue for the past five years, LUCD makes an average of $4,192.33 per day.
What was Lucid Diagnostics's annual revenue growth in the past year?
As of Q2 2025, Lucid Diagnostics's revenue has grown 79% year over year. This is 68.47 percentage points higher than the US Medical Devices industry revenue growth rate of 10.53%. Lucid Diagnostics's revenue in the past year totaled $4.35 million.
How much does Lucid Diagnostics make in a year?
Lucid Diagnostics's revenue by year for the past five years is:
Lucid Diagnostics's revenue for the twelve months ending Dec 31, 2024 was $4.35 million, a 79% increase year over year.
Lucid Diagnostics's annual revenue for Dec 31, 2023 was $2.43 million, a 544.03% increase from 2022.
Lucid Diagnostics's annual revenue for 2022 was $377.00 thousand, a 24.6% decrease from 2021.
Lucid Diagnostics's annual revenue for 2021 was $500.00 thousand, a Infinity% increase from 2020.
Lucid Diagnostics's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.